HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rongxing Liu Selected Research

Rongxing Liu Research Topics

Disease

6Neoplasms (Cancer)
01/2024 - 11/2019
2Hematologic Neoplasms (Hematological Malignancy)
06/2022 - 01/2021
2Leukemia
01/2021 - 01/2019
1Esophageal Squamous Cell Carcinoma
11/2023
1Neoplasm Metastasis (Metastasis)
11/2023
1Mouth Neoplasms (Oral Cancer)
01/2023
1Lymphoma (Lymphomas)
06/2022
1Obesity
06/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2022
1Autoimmune enteropathy
01/2022
1Liver Neoplasms (Liver Cancer)
11/2019

Drug/Important Bio-Agent (IBA)

3Protein Tyrosine PhosphatasesIBA
06/2022 - 01/2022
2EnzymesIBA
01/2021 - 01/2019
2Etoposide (VP 16)FDA LinkGeneric
01/2021 - 01/2019
1camrelizumabIBA
11/2023
1Antihypertensive Agents (Antihypertensives)IBA
01/2023
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2023
1Therapeutic UsesIBA
12/2022
16-pyruvoyltetrahydropterin synthase (PTPS)IBA
06/2022
1LipidsIBA
11/2019
1QuinoxalinesIBA
11/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2019
1SincalideFDA Link
11/2019
1quinone (benzoquinone)IBA
01/2019
1Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2019

Therapy/Procedure

2Therapeutics
01/2024 - 01/2021
1Neoadjuvant Therapy
11/2023
1Drug Therapy (Chemotherapy)
12/2022